谷歌浏览器插件
订阅小程序
在清言上使用

Clinical Impact of Expanded BRAF Mutational Status on the Outcome for Metastatic Colorectal Cancer Patients with Anti-Egfr Antibody: an Analysis of the BREAC Trial (biomarker Research for Anti-EGFR Monoclonal Antibodies by Comprehensive Cancer Genomics).

Journal of Clinical Oncology(2015)

引用 3|浏览29
暂无评分
关键词
BRAF Mutations,Metastatic Colorectal Cancer,EGFR Mutations,Metastatic Breast Cancer,Biomarker Analysis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要